We have seen 44 institutional investors add shares of $CCAP stock to their portfolio, and 44 decrease their positions in their most recent quarter.

Crescent Capital fundamentals remain robust with 107% dividend coverage, a conservative 40% portfolio LTV, and 2.2x interest coverage. See why CCAP stock is a buy.

Good morning, and welcome to Crescent Capital BDC, Inc.'s Fourth Quarter and Year Ended December 31, 2025 Earnings Conference Call. Please note that Crescent Capital BDC, Inc. may be referred to as ...

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the five research firms that are presently covering the firm, ...